Immunoglobulins, Intravenous
Showing 51 - 75 of 9,550
Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP), Kawasaki Syndrome Trial in United States (Immune
Completed
- Primary Immunodeficiency Diseases (PID)
- +2 more
- Immune Globulin Intravenous (Human), 10%
-
Los Angeles, California
- +10 more
Aug 22, 2021
Definition for Biliary Atresia Associated Cholangitis After
Recruiting
- Biliary Atresia
- Cholangitis
- Intravenous Antibodies
-
Nanjing, Jiangsu, ChinaNJMU
Jul 15, 2022
Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))
Not yet recruiting
- Secondary Antibody Deficiency
- Immunoglobulin replacement therapy (IGRT)
- (no location specified)
Nov 4, 2022
Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin
Recruiting
- Myasthenia Gravis
- subcutaneous immunoglobulin (SCIG)
- intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
-
Toronto, Ontario, CanadaUniversity Health Network
Nov 21, 2022
Shock, Septic, Sepsis, Hypoglobulinemia Trial in Modena (IgM-enriched polyclonal immunoglobulins titer-based treatment,
Recruiting
- Shock, Septic
- +2 more
- IgM-enriched polyclonal immunoglobulins titer-based treatment
- IgM-enriched polyclonal immunoglobulins Flat treatment
-
Modena, ItalyICU- University Hospital Modena
May 3, 2021
Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)
Not yet recruiting
- Aplastic Anemia
- Ciclosporin
- +2 more
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia Trial in Finland, Sweden (Immune Globulin
Completed
- Primary Immunodeficiency Diseases (PID)
- +2 more
- Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
- Gammagard S/D (Solvent/Detergent)
-
Tampere, Finland
- +5 more
Aug 22, 2021
COVID-19 Trial in Abu Dhabi (Human COVID-19 immunoglobulin (pH4) for intravenous injection, Placebo)
Not yet recruiting
- COVID-19
- Human COVID-19 immunoglobulin (pH4) for intravenous injection
- Placebo
-
Abu Dhabi, United Arab EmiratesAl Rahba Hospital
Dec 30, 2021
Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin
Not yet recruiting
- Immune Thrombocytopenia
- Pregnancy Related
- intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- intravenous immunoglobulin
- (no location specified)
Dec 1, 2022
Kenota 1 CWS Method Comparison Validation Study
Recruiting
- Allergy
- Immunoglobulin E-Mediated Allergic Disorder
- Total Immunoglobulin E, Obtained From Fingerstick Sample
-
Saint Paul, Minnesota
- +2 more
Jan 27, 2023
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
Primary Immunodeficiency Trial in United States (IGSC 20%)
Completed
- Primary Immunodeficiency
- IGSC 20%
-
Birmingham, Alabama
- +11 more
Nov 2, 2022
COVID-19 Trial in New York (COVID-HIGIV, Placebo (saline))
Completed
- COVID-19
- COVID-HIGIV
- Placebo (saline)
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 15, 2021
Kidney Transplantation Trial in Paris (Privigen (Human normal immunoglobulin G (IgG > 98 % purity)))
Completed
- Kidney Transplantation
- Privigen (Human normal immunoglobulin G (IgG > 98 % purity))
-
Paris, Ile De France, FranceService de Néphrologie et transplantation rénale - HU Saint-Loui
Mar 8, 2021
Dysmotility Syndrome, Autoimmunity Trial in Baltimore (Current Intravenous Immunoglobulin (IVIG) treatment, No Intravenous
Recruiting
- Dysmotility Syndrome
- Autoimmunity
- Current Intravenous Immunoglobulin (IVIG) treatment
- No Intravenous Immunoglobulin (IVIG) treatment
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Mar 8, 2022
Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)
Recruiting
- Lung Transplant
- Hepatitis B
- Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
-
Philadelphia, PennsylvaniaHospital of University of Pennsylvania
Oct 1, 2022
Steroid-Dependent Nephrotic Syndrome Trial in Paris (immunoglobulin IV)
Suspended
- Steroid-Dependent Nephrotic Syndrome
- immunoglobulin IV
-
Paris, FranceRobert Debre Hospital
Oct 1, 2021
Stiff-Person Syndrome Trial in Rochester (Intravenous Immunoglobulins, Human, Placebos)
Withdrawn
- Stiff-Person Syndrome
- Intravenous Immunoglobulins, Human
- Placebos
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 11, 2019
Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)
Recruiting
- Transplant Rejection
- BIVV020
- +6 more
-
Westmead, New South Wales, Australia
- +14 more
Aug 2, 2022
COVID-19, SARS-CoV2 Trial in Miami Beach, Omaha, Sioux Falls (SAB-185, Normal Saline)
Active, not recruiting
- COVID-19
- SARS-CoV2
- SAB-185
- Normal Saline
-
Miami Beach, Florida
- +2 more
Oct 25, 2021
IgG Subclasses and on Immunity of Secondary Immunodeficiency
Completed
- Secondary Immune Deficiency
- Gammanorm
- Other Subcutaneous Immunoglobulins
-
Chalon-sur-Saône, France
- +5 more
Feb 28, 2022
Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural
Not yet recruiting
- Rabies Virus Infection
- Natural full human monoclonal antibody CBB 1 injection
- +3 more
-
Kunming, Yunnan, ChinaThe First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023
Guillain-Barre Syndrome Trial in Assiut (plasmapheresis device, Intravenous immunoglobulin)
Completed
- Guillain-Barre Syndrome
- plasmapheresis device
- Intravenous immunoglobulin
-
Assiut, EgyptAssiut university
Oct 27, 2022